Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Mar 22;21(1):138.
doi: 10.1186/s12887-021-02618-y.

Newborn antibodies to SARS-CoV-2 detected in cord blood after maternal vaccination - a case report

Gilbert Paul  1 , Rudnick Chad  2   3
Affiliations
Case Reports

Newborn antibodies to SARS-CoV-2 detected in cord blood after maternal vaccination - a case report

Gilbert Paul et al. BMC Pediatr. .

Abstract

Background: Maternal vaccination for Influenza and Tetanus, Diphtheria, acellular Pertussis (TDaP) have been well studied in terms of safety and efficacy for protection of the newborn by placental passage of antibodies. Similar newborn protection would be expected after maternal vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19). There is a significant and urgent need for research regarding safety and efficacy of vaccination against SARS-CoV-2 during pregnancy.

Case presentation: A vigorous, healthy, full-term female was born to a COVID-19 naïve mother who had received a single dose of messenger RNA (mRNA) vaccine for SARS-CoV-2 3 weeks prior to delivery. IgG cord blood antibodies were detected to SARS-CoV-2 at the time of birth.

Conclusion: Here, we report the first known case of an infant with SARS-CoV-2 IgG antibodies detectable in cord blood after maternal vaccination.

Keywords: COVID-19; Cord blood; Maternal; Newborn; Vaccination.

PubMed Disclaimer

Conflict of interest statement

The authors have competing interests to disclose.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Woo PC, Lau SK, Wong BH, et al. Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked Immunosorbent assay (ELISA) and SARS coronavirus Nucleocapsid protein ELISA for Serodiagnosis of SARS coronavirus pneumonia. J Clin Microbiol. 2005;43(7):3054–3058. doi: 10.1128/JCM.43.7.3054-3058.2005. - DOI - PMC - PubMed
    1. Hardy-Fairbanks AJ, et al. Immune responses in infants whose mother received tdap vaccine during pregnancy. Pediatr Infect Dis J. 2013;32(11):1257–1260. doi: 10.1097/INF.0b013e3182a09b6a. - DOI - PubMed
    1. Walls T, et al. Infant outcomes after exposure to Tdap vaccine in pregnancy: an observation study. BMJ Open. 2016;6:e009536. doi: 10.1136/bmjopen-2015-009536. - DOI - PMC - PubMed
    1. Baxter R, et al. Effectiveness of vaccination during pregnancy to prevent infant pertussis. Pediatrics. 2017;139(5):e20164091. doi: 10.1542/peds.2016-4091. - DOI - PubMed
    1. Black SB, et al. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness and in pregnant women and their infants. Am J Perinatol. 2004;21(6):p333–p339. doi: 10.1055/s-2004-831888. - DOI - PubMed

Publication types